Skip to main navigation Skip to search Skip to main content

ROSETTA Gastric-204: A Blinded, Randomized, Phase 2/3 Study of Pumitamig in Combination with Chemotherapy Versus Nivolumab in Combination with Chemotherapy in Participants with Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

  • Lau, David (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusActive
Effective start/end date30/03/26 → 29/03/31

Clinical Trial Phase

  • Phase II
  • Phase III (a & b)
  • External Sponsor